Kyle Wool Biography and Net Worth

President of Dominari

Kyle M. Wool, President to the Dominari Holdings Inc. Board of Directors and CEO of Dominari Financial Inc. and the CEO of Dominari Securities. He boasts over 20 years in various aspects of global finance as a Managing Director at Oppenheimer & Co., Head of Wealth Management for their Asian branch, Executive Director at Morgan Stanley, and President of Revere Securities LLC. His extensive knowledge allows him to provide invaluable strategic guidance while advising those on the team managing all facets related to financial services categories with senior level insights that ensure success across the board within an organization whose growth strategies he actively contributes towards cultivating.

Kyle is also active in various philanthropic endeavors both domestically and abroad. He currently serves as a board member of LifeLine NY, board member of the CIRSD (Center for International Relations and Sustainable Development), board member of Project Rousseau and also a board Member of Lang Lang International Music Foundation.

Kyle is a regular contributor to Fox Business on shows such as, Mornings with Maria, The Stuart Varney show and The Claman Countdown.

What is Kyle Michael Wool's net worth?: The estimated net worth of Kyle Michael Wool is at least $11.04 million as of September 10th, 2026. Mr. Wool owns 4,261,828 shares of Dominari stock worth more than $11,038,135 as of September 22nd. This net worth evaluation does not reflect any other investments that Mr. Wool may own. Learn More about Kyle Michael Wool's net worth.
How do I contact Kyle Michael Wool?: The corporate mailing address for Mr. Wool and other Dominari executives is 725 Fifth Avenue, 22nd Floor, New York, NY, 10022. Dominari can also be reached via phone at (212) 393-4540 and via email at [email protected]. Learn More on Kyle Michael Wool's contact information.
Has Kyle Michael Wool been buying or selling shares of Dominari?: During the last ninety days, Kyle Michael Wool has bought $101,000.00 in Dominari stock. Most recently, on Thursday, September 10th, Kyle Michael Wool bought 50,000 shares of Dominari stock. The stock was acquired at an average cost of $2.02 per share, with a total value of $101,000.00. Following the completion of the transaction, the president now directly owns 4,261,828 shares of the company's stock, valued at $8,608,892.56. Learn More on Kyle Michael Wool's trading history.
Who are Dominari's active insiders?: Dominari's insider roster includes Christopher Devall (COO), Anthony Hayes (CEO), and Kyle Wool (President). Learn More on Dominari's active insiders.
Are insiders buying or selling shares of Dominari?: During the last year, Dominari insiders bought shares 2 times. They purchased a total of 100,000 shares worth more than $202,000.00. During the last year, insiders at the sold shares 3 times. They sold a total of 225,000 shares worth more than $876,850.00. The most recent insider tranaction occured on September, 10th when CEO Anthony Hayes bought 50,000 shares worth more than $101,000.00. Insiders at Dominari own 55.3% of the company. Learn More about insider trades at Dominari.
Information on this page was last updated on 9/10/2026.

Kyle Michael Wool Insider Trading History at Dominari

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/10/2026	Buy	50,000	$2.02	$101,000.00	4,261,828
5/29/2024	Buy	5,000	$2.20	$11,000.00	27,750
4/8/2024	Buy	8,500	$2.99	$25,415.00	22,750
4/4/2024	Buy	19,000	$2.87	$54,530.00	18,500
12/26/2023	Buy	5,000	$2.60	$13,000.00	9,000
12/26/2023	Buy	5,000	$2.60	$13,000.00	9,000
9/19/2023	Buy	2,000	$2.55	$5,100.00	6,000
9/11/2023	Buy	2,000	$2.82	$5,640.00	2,000
8/25/2023	Buy	2,000	$2.90	$5,800.00	818,858
8/21/2023	Buy	1,000	$2.99	$2,990.00	816,858
8/18/2023	Buy	1,369	$2.95	$4,038.55	815,858
8/14/2023	Buy	2,000	$3.00	$6,000.00	814,489
6/8/2023	Buy	424	$2.59	$1,098.16	281,274
5/30/2023	Buy	2,000	$2.59	$5,180.00	280,850
5/18/2023	Buy	2,000	$2.94	$5,880.00	278,792

Kyle Michael Wool Buying and Selling Activity at Dominari

Dominari Company Overview

Dominari Holdings Inc., a biotechnology company, focuses on developing small-molecule anticancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. It has license agreements with the University of Texas, Silo Pharma Inc., and Wake Forest University Health Sciences. The company was formerly known as AIkido Pharma Inc. and changed its name to Dominari Holdings Inc. in December 2022. Dominari Holdings Inc. was founded in 1967 and is headquartered in New York, New York.

Today's Range

Now: $2.56

$2.48

$2.60

50 Day Range

MA: $2.50

$1.94

$3.14

2 Week Range

Now: $2.56

$1.91

$8.40

Volume

372,049 shs

Average Volume

162,323 shs

Market Capitalization

$62.05 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.87